| Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delay A Deodhar, M Mittal, P Reilly, Y Bao, S Manthena, J Anderson, A Joshi Clinical rheumatology 35, 1769-1776, 2016 | 92 | 2016 |
| Impact of a patient support program on patient adherence to adalimumab and direct medical costs in Crohn’s disease, ulcerative colitis, rheumatoid arthritis, psoriasis … DT Rubin, M Mittal, M Davis, S Johnson, J Chao, M Skup Journal of managed care & specialty pharmacy 23 (8), 859-867, 2017 | 82 | 2017 |
| Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database D Wendling, A Joshi, P Reilly, YJ Jalundhwala, M Mittal, Y Bao Current medical research and opinion 30 (12), 2515-2521, 2014 | 76 | 2014 |
| ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work … D van der Heijde, A Joshi, AL Pangan, N Chen, K Betts, M Mittal, Y Bao Rheumatology 55 (1), 80-88, 2016 | 72 | 2016 |
| Corticosteroid-related adverse events systematically increase with corticosteroid dose in noninfectious intermediate, posterior, or panuveitis: post hoc analyses from the … EB Suhler, JE Thorne, M Mittal, KA Betts, S Tari, A Camez, Y Bao, A Joshi Ophthalmology 124 (12), 1799-1807, 2017 | 36 | 2017 |
| Clinical outcomes associated with switching or discontinuation from anti-TNF inhibitors for nonmedical reasons D Wolf, M Skup, H Yang, AP Fang, A Kageleiry, J Chao, M Mittal, ... Clinical therapeutics 39 (4), 849-862. e6, 2017 | 35 | 2017 |
| Network meta-analysis and cost per responder of tumor necrosis factor-α and interleukin inhibitors in the treatment of active ankylosing spondylitis KA Betts, J Griffith, Y Song, M Mittal, A Joshi, EQ Wu, A Ganguli Rheumatology and Therapy 3, 323-336, 2016 | 27 | 2016 |
| Comparative effectiveness of adalimumab versus secukinumab for the treatment of psoriatic arthritis: a matching-adjusted indirect comparison V Strand, KA Betts, M Mittal, J Song, M Skup, A Joshi Rheumatology and therapy 4, 349-362, 2017 | 26 | 2017 |
| Effects of non-medical switching on outcomes among patients prescribed tumor necrosis factor inhibitors A Gibofsky, M Skup, M Mittal, SJ Johnson, M Davis, J Chao, DT Rubin Current medical research and opinion 33 (11), 1945-1953, 2017 | 19 | 2017 |
| National antidepressant prescribing in children and adolescents with mental health disorders after an FDA boxed warning M Mittal, DL Harrison, MJ Miller, NC Brahm Research in Social and Administrative Pharmacy 10 (5), 781-790, 2014 | 16 | 2014 |
| OP0115 Relative Efficacy of Adalimumab versus Secukinumab in Active Ankylosing Spondylitis: A Matching-Adjusted Indirect Comparison KA Betts, M Mittal, J Song, M Skup, A Joshi Annals of the Rheumatic Diseases 75 (Suppl 2), 98-99, 2016 | 15 | 2016 |
| Have antiepileptic drug prescription claims changed following the FDA suicidality warning? An evaluation in a state Medicaid program M Mittal, DL Harrison, MJ Miller, KC Farmer, DM Thompson, YT Ng Epilepsy & Behavior 34, 109-115, 2014 | 14 | 2014 |
| SAT0578 value of treating both skin and joint manifestations of psoriatic arthritis: post-hoc analysis of the adept clinical trial PJ Mease, M Mittal, A Joshi, N Chen, J Anderson, Y Bao Annals of the Rheumatic Diseases 74 (Suppl 2), 870-870, 2015 | 5 | 2015 |
| Effect of adalimumab on visual functioning (VFQ-25) in VISUAL-1 trial patients with non-anterior non-infectious uveitis JD Sheppard, A Joshi, M Mittal, K Betts, SR Tari, Y Bao, AD Dick Investigative Ophthalmology & Visual Science 56 (7), 1723-1723, 2015 | 4 | 2015 |
| Relative efficacy of adalimumab versus secukinumab in active psoriatic arthritis: a matching-adjusted indirect comparison K Betts, M Mittal, A Joshi, J Song, Y Bao JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 74 (5), AB267-AB267, 2016 | 3 | 2016 |
| An evaluation of three statistical estimation methods for assessing health policy effects on prescription drug claims M Mittal, DL Harrison, DM Thompson, MJ Miller, KC Farmer, YT Ng Research in Social and Administrative Pharmacy 12 (1), 29-40, 2016 | 3 | 2016 |
| SAT0237 Assessment of Salary Growth in Patients with Ankylosing Spondylitis Treated with and Without Anti-Tumor Necrosis Factor Therapy A Deodhar, M Mittal, A Joshi, JE Signorovitch, M Yang, Y Bao Annals of the Rheumatic Diseases 74 (Suppl 2), 744-744, 2015 | 2 | 2015 |
| SAT0339 Asas40 and ASDAS Responses Are Associated with Improved Physical Function, Hrqol, and Work Productivity in Patients with Non-Radiographic Axial Spondyloarthritis D van der Heijde, A Joshi, M Mittal, A Pangan, N Chen, K Betts, C Qi, ... Annals of the Rheumatic Diseases 73 (Suppl 2), 715-715, 2014 | 1 | 2014 |
| Impact of a patient support program on adherence and healthcare costs in patients with psoriasis and psoriatic arthritis B Strober, M Skup, M Mittal, M Davis, M Sundaram, S Johnson, J Chao JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 30, 60-60, 2016 | | 2016 |
| Real-World Impact of Anti-TNF Medication Use on Patient Reported Outcomes in a Prospective Cohort of Patients with Ankylosing Spondylitis W Maksymowych, A Boonen, H Marzo-Ortega, MN Magrey, M Mittal, ... ARTHRITIS & RHEUMATOLOGY 67, 2015 | | 2015 |
